1
|
Escourrou G, Renesme L, Zana E, Rideau A, Marcoux MO, Lopez E, Gascoin G, Kuhn P, Tourneux P, Guellec I, Flamant C. How to assess hemodynamic status in very preterm newborns in the first week of life? J Perinatol 2017; 37:987-993. [PMID: 28471441 DOI: 10.1038/jp.2017.57] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2016] [Revised: 02/12/2017] [Accepted: 03/28/2017] [Indexed: 01/02/2023]
Abstract
BACKGROUND Assessing hemodynamic status in preterm newborns is an essential task, as many studies have shown increased morbidity when hemodynamic parameters are abnormal. Although oscillometric monitoring of arterial blood pressure (BP) is widely used due to its simplicity and lack of side effects, these values are not always correlated with microcirculation and oxygen delivery. OBJECTIVES This review focuses on different tools for the assessment of hemodynamic status in preterm newborns. These include the measurement of clinical (BP, capillary refill time and urinary output (UO)) or biological parameters (lactate analysis), functional echocardiography, and near-infrared spectroscopy (NIRS). We describe the concepts and techniques involved in these tools in detail, and examine the interest and limitations of each type of assessment. CONCLUSIONS This review highlights the complementarities between the different parameters used to assess hemodynamic status in preterm newborns during the first week of life. The analysis of arterial BP measured by oscillometric monitoring must take into account other clinical data, in particular capillary refill time and UO, and biological data such as lactate levels. Echocardiography improves noninvasive hemodynamic management in newborns but requires specific training. In contrast, NIRS may be useful in monitoring the clinical course of infants at risk of, or presenting with, hypotension. It holds the potential for early and noninvasive identification of silent hypoperfusion in critically ill preterm infants. However, more data are needed to confirm the usefulness of this promising tool in significantly changing the outcome of these infants.
Collapse
Affiliation(s)
- G Escourrou
- Department of Neonatal Medicine, CH Montreuil, Montreuil, France
| | - L Renesme
- Department of Neonatal Medicine, CHU Bordeaux, France
| | - E Zana
- Department of Neonatal Medicine, Port Royal Maternity, Paris, France
| | - A Rideau
- Department of Neonatal Medicine, CHU Paris, France
| | - M O Marcoux
- Paediatric Intensive Care Unit, CHU Toulouse, France
| | - E Lopez
- Department of Neonatal Medicine, CHU Tours, France
| | - G Gascoin
- Department of Neonatal Medicine, CHU Angers, France
| | - P Kuhn
- Department of Neonatal Medicine, CHU Strasbourg, France
| | - P Tourneux
- Department of Neonatal Medicine, CHU Amiens, France
| | - I Guellec
- Department of Neonatal Medicine, CHU Paris, France
| | - C Flamant
- Department of Neonatal Medicine, CHU Nantes, Service de Réanimation néonatale, Nantes, France
| |
Collapse
|
2
|
Wang YY, Attané C, Milhas D, Dirat B, Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, Le Gonidec S, Biard D, Hervé C, Bost F, Ren GS, Bono F, Escourrou G, Prentki M, Nieto L, Valet P, Muller C. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight 2017; 2:e87489. [PMID: 28239646 DOI: 10.1172/jci.insight.87489] [Citation(s) in RCA: 279] [Impact Index Per Article: 39.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
In breast cancer, a key feature of peritumoral adipocytes is their loss of lipid content observed both in vitro and in human tumors. The free fatty acids (FFAs), released by adipocytes after lipolysis induced by tumor secretions, are transferred and stored in tumor cells as triglycerides in lipid droplets. In tumor cell lines, we demonstrate that FFAs can be released over time from lipid droplets through an adipose triglyceride lipase-dependent (ATGL-dependent) lipolytic pathway. In vivo, ATGL is expressed in human tumors where its expression correlates with tumor aggressiveness and is upregulated by contact with adipocytes. The released FFAs are then used for fatty acid β-oxidation (FAO), an active process in cancer but not normal breast epithelial cells, and regulated by coculture with adipocytes. However, in cocultivated cells, FAO is uncoupled from ATP production, leading to AMPK/acetyl-CoA carboxylase activation, a circle that maintains this state of metabolic remodeling. The increased invasive capacities of tumor cells induced by coculture are completely abrogated by inhibition of the coupled ATGL-dependent lipolysis/FAO pathways. These results show a complex metabolic symbiosis between tumor-surrounding adipocytes and cancer cells that stimulate their invasiveness, highlighting ATGL as a potential therapeutic target to impede breast cancer progression.
Collapse
Affiliation(s)
- Yuan Yuan Wang
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS.,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, INSERM, UPS, Toulouse, France.,Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Camille Attané
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, INSERM, UPS, Toulouse, France
| | - Delphine Milhas
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | - Béatrice Dirat
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS.,Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, INSERM, UPS, Toulouse, France
| | - Stéphanie Dauvillier
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | - Adrien Guerard
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | - Julia Gilhodes
- Departement de Biostatistiques, Institut Universitaire du Cancer, Toulouse, France
| | - Ikrame Lazar
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | | | - Victor Laurent
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | - Sophie Le Gonidec
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, INSERM, UPS, Toulouse, France
| | | | | | - Frédéric Bost
- Institut National de la Santé et de la Recherche Médicale, U1065, Centre Méditerranéen de Médecine Moléculaire, Nice, France
| | - Guo Sheng Ren
- Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | | | - Ghislaine Escourrou
- Service d'Anatomo-Pathologie, Institut Universitaire du Cancer, Toulouse, France
| | - Marc Prentki
- Departments of Nutrition and Biochemistry and Montreal Diabetes Research Center, CRCHUM and Université de Montréal, Montréal, Quebec, Canada
| | - Laurence Nieto
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| | - Philippe Valet
- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université de Toulouse, INSERM, UPS, Toulouse, France
| | - Catherine Muller
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS
| |
Collapse
|
3
|
Vaysse C, Philippe C, Martineau Y, Quelen C, Hieblot C, Renaud C, Nicaise Y, Desquesnes A, Pannese M, Filleron T, Escourrou G, Lawson M, Rintoul RC, Delisle MB, Pyronnet S, Brousset P, Prats H, Touriol C. Key contribution of eIF4H-mediated translational control in tumor promotion. Oncotarget 2016; 6:39924-40. [PMID: 26498689 PMCID: PMC4741870 DOI: 10.18632/oncotarget.5442] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2015] [Accepted: 10/03/2015] [Indexed: 02/06/2023] Open
Abstract
Dysregulated expression of translation initiation factors has been associated with carcinogenesis, but underlying mechanisms remains to be fully understood. Here we show that eIF4H (eukaryotic translation initiation factor 4H), an activator of the RNA helicase eIF4A, is overexpressed in lung carcinomas and predictive of response to chemotherapy. In lung cancer cells, depletion of eIF4H enhances sensitization to chemotherapy, decreases cell migration and inhibits tumor growth in vivo, in association with reduced translation of mRNA encoding cell-proliferation (c-Myc, cyclin D1) angiogenic (FGF-2) and anti-apoptotic factors (CIAP-1, BCL-xL). Conversely, each isoform of eIF4H acts as an oncogene in NIH3T3 cells by stimulating transformation, invasion, tumor growth and resistance to drug-induced apoptosis together with increased translation of IRES-containing or structured 5′UTR mRNAs. These results demonstrate that eIF4H plays a crucial role in translational control and can promote cellular transformation by preferentially regulating the translation of potent growth and survival factor mRNAs, indicating that eIF4H is a promising new molecular target for cancer therapy.
Collapse
Affiliation(s)
- Charlotte Vaysse
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Céline Philippe
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Yvan Martineau
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Cathy Quelen
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Corinne Hieblot
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Claire Renaud
- Department of Thoracic Surgery, Rangueil-Larrey Hospital, Toulouse, France
| | - Yvan Nicaise
- Department of Pathology, CHU Rangueil, Toulouse, France
| | | | | | - Thomas Filleron
- Clinical Trial Office, Cellule Biostatistique Institut Universitaire du Cancer Toulouse, Toulouse, France
| | - Ghislaine Escourrou
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Department of Pathology, CHU Rangueil, Toulouse, France
| | - Malcolm Lawson
- Department of Respiratory Medicine, Broomfield Hospital, Chelmsford, Essex, UK
| | - Robert C Rintoul
- Department of Thoracic Oncology, Papworth Hospital, Cambridge, UK
| | - Marie Bernadette Delisle
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Department of Pathology, CHU Rangueil, Toulouse, France
| | - Stéphane Pyronnet
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Pierre Brousset
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France.,Department of Pathology, Institut Universitaire du Cancer, Toulouse, France
| | - Hervé Prats
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| | - Christian Touriol
- INSERM U1037, CRCT, Cancer Research Center of Toulouse, Toulouse, France.,Toulouse University, Paul Sabatier, Toulouse, France
| |
Collapse
|
4
|
Quintyn-Ranty ML, Gordien K, Caveriviere P, Mery É, Jamme-Lallemand M, Wuithier P, Palasse J, Reyre J, Laborie V, Despax B, Rolland V, Thibaut I, Maissongrosse V, Escourrou G, Duprez-Paumier R, Bauvin É, Jacob M, Lacroix-Triki M. [Improving practice in breast pathology: 34-months experience of the regional SENOPATH network and webinars as a tool for diagnosis of difficult lesions of the breast]. Bull Cancer 2015; 102:823-33. [PMID: 26384691 DOI: 10.1016/j.bulcan.2015.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2015] [Revised: 07/09/2015] [Accepted: 07/13/2015] [Indexed: 10/23/2022]
Abstract
Pathologists commonly face breast lesions that are difficult to diagnose. To reduce second opinion delay, erase geographical barrier and provide continuing education, we aimed to develop a telepathology-based regional network of pathologists. With the support of ONCOMIP network, we founded a peer-group named SENOPATH, composed of experienced breast pathologists practising in private laboratories, university hospitals or comprehensive cancer center in the region of Midi-Pyrénées in France. Submitted cases are digitalized at the University Hospital, stored in a shared space with a possible access via Internet prior to the SENOPATH sessions. The group meets monthly, via a synchronized webinar and multihead microscope session. A consensual diagnosis and final pathology report is issued for each case, and sent to the referring clinician via the patient medical file securely hosted by ONCOMIP. Between 2012 and 2014, 142 cases were reviewed, for either diagnostic 'routine' difficulty or rare histological type. The SENOPATH group, also regularly called by oncologists to solve difficult cases, has considerably improved the pathologist network in Southern France. Supported by the webinar tool, its educational impact is prominent, with a considerable progress in the region with regards to standardization of pathology processes, literature review and knowledge sharing.
Collapse
Affiliation(s)
- Marie-Laure Quintyn-Ranty
- CHU de Toulouse, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Karine Gordien
- Réseau de cancérologie de Midi-Pyrénées ONCOMIP, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Paul Caveriviere
- Laboratoire d'anatomie et de cytologie pathologiques des feuillants, 116, route d'Espagne, 31000 Toulouse, France
| | - Éliane Mery
- Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Muriel Jamme-Lallemand
- Clinique Claude-Bernard, service d'anatomie et de cytologie pathologiques, 1, rue Père-Colombier, 81030 Albi cedex 09, France
| | - Pascal Wuithier
- Laboratoire d'anatomie et de cytologie pathologiques, 13, rue Carnot, 65000 Tarbes, France
| | - Julien Palasse
- Laboratoire d'anatomie et de cytologie pathologiques, 9, rue Viscose, 31100 Toulouse, France
| | - Joelle Reyre
- Laboratoire d'anatomie et de cytologie pathologiques des feuillants, 116, route d'Espagne, 31000 Toulouse, France
| | - Vincent Laborie
- Laboratoire d'anatomie et de cytologie pathologiques de Montauban, 43, avenue Charles-de-Gaulle, 82000 Montauban, France
| | - Brigitte Despax
- Laboratoire d'anatomie et de cytologie pathologiques, 62, boulevard des récollets, 31400 Toulouse, France
| | - Véronique Rolland
- Laboratoire d'anatomie et de cytologie pathologiques, 62, boulevard des récollets, 31400 Toulouse, France
| | - Isabelle Thibaut
- Centre de pathologie des coteaux, 5, rue Boyssonne, BP 14001, 31078 Toulouse cedex 4, France
| | - Véronique Maissongrosse
- Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Ghislaine Escourrou
- CHU de Toulouse, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Raphaëlle Duprez-Paumier
- CHU de Toulouse, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Éric Bauvin
- Réseau de cancérologie de Midi-Pyrénées ONCOMIP, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
| | - Michel Jacob
- Université Paul-Sabatier, département TIC/TICE et multimédia (DTSI), 118, route de Narbonne, 31062 Toulouse cedex 9, France
| | - Magali Lacroix-Triki
- Institut Claudius-Regaud, service d'anatomie et de cytologie pathologiques, IUCT-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.
| |
Collapse
|
5
|
Escourrou G, Bellat-Ettreiki C, Le Sache N, Croisier D, Bertin D, Rimensberger P, Tissieres P. SFP CO-65 - L’ interféron-gamma améliore les capacités de réponse antibactérienne dans un modèle murin de sepsis néonatal à Escherichia coli. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71903-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Bochet L, Lehuédé C, Dauvillier S, Wang YY, Dirat B, Laurent V, Dray C, Guiet R, Maridonneau-Parini I, Le Gonidec S, Couderc B, Escourrou G, Valet P, Muller C. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 2013; 73:5657-68. [PMID: 23903958 DOI: 10.1158/0008-5472.can-13-0530] [Citation(s) in RCA: 323] [Impact Index Per Article: 29.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Cancer-associated fibroblasts (CAF) comprise the majority of stromal cells in breast cancers, yet their precise origins and relative functional contributions to malignant progression remain uncertain. Local invasion leads to the proximity of cancer cells and adipocytes, which respond by phenotypical changes to generate fibroblast-like cells termed as adipocyte-derived fibroblasts (ADF) here. These cells exhibit enhanced secretion of fibronectin and collagen I, increased migratory/invasive abilities, and increased expression of the CAF marker FSP-1 but not α-SMA. Generation of the ADF phenotype depends on reactivation of the Wnt/β-catenin pathway in response to Wnt3a secreted by tumor cells. Tumor cells cocultivated with ADFs in two-dimensional or spheroid culture display increased invasive capabilities. In clinical specimens of breast cancer, we confirmed the presence of this new stromal subpopulation. By defining a new stromal cell population, our results offer new opportunities for stroma-targeted therapies in breast cancer.
Collapse
Affiliation(s)
- Ludivine Bochet
- Authors' Affiliations: Université de Toulouse, UPS; CNRS; Institut de Pharmacologie et de Biologie Structurale; Institut National de la Santé et de la Recherche Médicale, INSERM U1048; Institut Claudius Regaud, EA3035; and Service d'Anatomo-Pathologie, Hôpital de Rangueil, Toulouse, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Simon C, Grunenwald S, Soule-Tholy M, Escourrou G, Vezzosi D, Deslandres M, Vidal F, Bennet A, Caron P. Synchronous intrathyroid metastasis from undifferentiated endometrial sarcoma. Thyroid 2013; 23:902-3. [PMID: 23360518 DOI: 10.1089/thy.2012.0594] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
8
|
Capuani C, Quintyn-Ranty ML, Escourrou G, Rimailho J, Delisle MB. [A misleading ovarian tumor of the young woman]. Ann Pathol 2013; 33:70-2. [PMID: 23472900 DOI: 10.1016/j.annpat.2012.09.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2011] [Revised: 09/19/2012] [Accepted: 09/30/2012] [Indexed: 11/26/2022]
Affiliation(s)
- Caroline Capuani
- Service d'anatomie pathologique et d'histologie-cytologie, CHU de Rangueil, 1, avenue Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
| | | | | | | | | |
Collapse
|
9
|
Boussaïd K, Meduri G, Maiza JC, Gennero I, Escourrou G, Bros A, Leguevaque P, Bennet A, Caron P. Virilizing sclerosing-stromal tumor of the ovary in a young woman with McCune Albright syndrome: clinical, pathological, and immunohistochemical studies. J Clin Endocrinol Metab 2013; 98:E314-20. [PMID: 23365131 DOI: 10.1210/jc.2012-3551] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
CONTEXT McCune-Albright syndrome (MAS) is characterized by polyostotic fibrous dysplasia, café-au-lait skin pigmentations, and gonadotropin-independent sexual precocious puberty, resulting from a somatic postzygotic activating mutation of the GNAS1 gene. SETTING We report a virilizing sclerosing-stromal tumor of the ovary in a young female with MAS. PATIENT She presented polyostotic fibrous dysplasia of the left upper and lower limbs and a café-au-lait skin spot in the posterior area of the neck. She had a history of precocious puberty, diagnosed at the age of 6 years and treated with cyproterone acetate until the age of 10 years; then she developed central puberty with severe oligomenorrhea. At the age of 23 years, she was hospitalized for a virilization syndrome including hirsutism, acne, deepening of the voice, amenorrhea, and clitoromegaly. Serum levels of T were dramatically increased (1293 ng/dl; normal range, 10-80). The abdominal computed tomography scan revealed a solid mass located on the left ovary. INTERVENTION An ovariectomy was performed, and histological examination revealed a sclerosing-stromal tumor with pseudolobular pattern. RESULTS Immunohistochemical studies revealed that the tumor cells expressed all steroidogenic enzymes involved in androgen synthesis. Molecular analysis revealed that ovarian tumor cells harbored the Arg 201 activating mutation in the GNAS1 gene. After surgery, T levels returned to normal, the patient retrieved a normal gonadal function, and she was able to become pregnant. CONCLUSION This observation extends the clinical spectrum of ovarian pathology of women with MAS. However, the mechanisms causing this ovarian tumor remain unclear, even if the gsp oncogene has been implicated in the pathogenesis of some gonadal tumors.
Collapse
Affiliation(s)
- Kahina Boussaïd
- Department of Endocrinology and Metabolic Diseases, Centre Hospitalier Universitaire Rangueil-Larrey, 24 Chemin de Pourvouville, TSA 30030, 31059 Toulouse Cedex 9, France
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Lacroix-Triki M, Delrée P, Filleron T, Penault-Llorca F, Bor C, Mery E, Maisongrosse V, Génin P, Jacquemier J, Reyre J, Caveriviere P, Quintyn-Ranty ML, Escourrou G, Mesleard C, Lemonnier J, Martin AL, Campone M. Abstract P3-05-07: Poor prognosis early breast cancer: pathological characteristics of the Unicancer-PACS08 trial including patients treated with docetaxel or ixabepilone in adjuvant setting. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p3-05-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The PACS08 trial aimed to compare adjuvant FEC100-Docetaxel regimen to FEC100-Ixabepilone (Ixa) in poor prognosis early breast cancer (BC). The study population included BC patients presenting with triple-negative (TN) [i.e. estrogen receptor (ER)−/progesterone receptor (PR)−/HER2−] or ER+/PR−/HER2− tumor, which are subgroups significantly associated with worse prognosis. Central review was performed and detailed pathological characteristics of the cohort are reported herein.
Patients and method: Between 2007 and 2010, 762 patients with unilateral TNBC (n = 592, 78%) or ER+/PR−/HER2− BC (n = 170, 22%) were enrolled. Recruitment was interrupted due to BMS decision to stop Ixa development in adjuvant setting. As defined by inclusion criteria, TNBC were either node+ or node-, and ER+/PR−/HER2− BC only node+. Following the validation of ER, PR and HER2 status on whole sections prior to inclusion, paraffin blocks (n = 754) were sent for central pathology review, tissue microarray (TMA) construction and constitution of the trial collection for translational research studies. Review of the cases (n = 754) was performed by a board of expert breast pathologists on a one-week working session with discussion of the difficult cases under a multihead microscope. Tumor characteristics were assessed on whole tissue sections. Immunohistochemical detection of Ki67, EGFR, cytokeratins (CK)5/6 and 14, was performed on TMAs.
Results: TNBC were significantly associated with younger age at diagnosis (median age 51yr vs 57.5yr in the ER+/PR- subgroup, p < 0.001). Most tumors were invasive ductal carcinomas (72%). Distribution of special histological subtypes was significantly different in the TNBC and ER+/PR−/HER2− subgroups, with the former comprising medullary (n = 16/17) and metaplastic (n = 34/34) subtypes while the latter was enriched in invasive lobular carcinomas (n = 27/35, p < 0.0001). TNBC were significantly associated with higher histological grade as compared to ER+/PR−/HER2− subgroup (Table 1). Accordingly, TNBC displayed significantly higher proliferative activity as shown by mitotic count and Ki67 index (p < 0.001). As compared to ER+/PR−/HER2− subgroup, TNBC showed distinct characteristics, and displayed a so-called basal-like phenotype in 80%. Among the ER+/PR−/HER2− subgroup, most tumors were classified as luminal B (64%). Interestingly, the presence of tumor lymphocytic infiltrate was more frequently observed in luminal B (59%) as compared to luminal A (30%) subtype (p < 0.001).
Conclusion: The Unicancer-PACS08 patient cohort is mainly composed of TNBC that harbour distinct pathological features. Description of the PACS08 collection provides a solid basis for translational research projects, which have been initiated with regards to genomic instability and DNA damage repair, immune system, and biomarker studies to identify new therapeutic targets.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P3-05-07.
Collapse
Affiliation(s)
- M Lacroix-Triki
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - P Delrée
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - T Filleron
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - F Penault-Llorca
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - C Bor
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - E Mery
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - V Maisongrosse
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - P Génin
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - J Jacquemier
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - J Reyre
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - P Caveriviere
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - M-L Quintyn-Ranty
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - G Escourrou
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - C Mesleard
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - J Lemonnier
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - A-L Martin
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| | - M Campone
- Institut Claudius Regaud, Toulouse, France; Institut de Pathologie et de Génétique, Gosselies, Belgium; Centre Jean Perrin, Clermont-Ferrand, France; Centre Francois Baclesse, Caen, France; Centre Alexis Vautrin, Vandoeuvre les Nancy, France; Institut Paoli Calmettes, Marseille, France; Laboratoire Anatomie et de Cytologie des Feuillants, Toulouse, France; CHU Rangueil, Toulouse, France; R&D Unicancer, Paris, France; ICO Centre René Gauducheau, Saint Herblain, France
| |
Collapse
|
11
|
Gordien K, Quintyn-Ranty ML, Caveriviere P, Mery E, Jamme-Lallemand M, Wuithier P, Palasse J, Reyre J, Laborie V, Despax B, Rolland V, Jacob M, Bosc R, Escourrou G, Bauvin E, Lacroix-Triki M. Amélioration des pratiques dans le domaine de la pathologie mammaire : mise en place d’une organisation régionale de relecture par télépathologie dans le cadre du groupe SENOPATH. Ann Pathol 2012. [DOI: 10.1016/j.annpat.2012.09.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
12
|
Socrier Y, D'Aure D, Lacoste-Collin L, Escourrou G, Soule-Tholy M, Delisle MB, Courtade-Saïdi M. Cytology of a thyroid metastasis from an endometrial sarcoma: a case report. Cytopathology 2012; 24:408-9. [PMID: 22775569 DOI: 10.1111/j.1365-2303.2012.00994.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Y Socrier
- Service d'Anatomie Pathologique et Histologie-CytologieService de Chirurgie Générale et Gynécologique, Hôpital de Rangueil, Toulouse Cedex, France
| | | | | | | | | | | | | |
Collapse
|
13
|
Gamé X, Bouali O, Allard J, Gourdy P, Escourrou G, Tack I, Rischmann P, Arnal J, Malavaud B. Influence of Sildenafil on Micturition and Urethral Tone in Ovariectomized and Non‐ovariectomized Mice. J Sex Med 2012; 9:466-71. [DOI: 10.1111/j.1743-6109.2011.02559.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
14
|
Quintyn-Ranty ML, Escourrou G, Paute A, Viale J, Guilbeau C, Delisle MB. [Micro-invasive vulvar Paget's disease and lymph node metastasis: a same disease?]. Ann Pathol 2011; 31:341-4. [PMID: 21982239 DOI: 10.1016/j.annpat.2011.06.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2009] [Accepted: 04/25/2009] [Indexed: 11/30/2022]
Abstract
Vulvar Paget's disease is sub-classified into three types based upon its origin. It might be a primary vulvar disease (type 1) or associated with a non-cutaneous adenocarcinoma-rectal, colonic, cervical (type 2) or linked with an urothelial neoplasia (type 3). Type 1lesions must be considered as potentially invasive. Their immunophenotype is CK7+/CK20-. Classically, in case of depth of invasion below 1mm, nodal metastases are exceptional. We report a case of type 1 Paget's disease in a postmenopausal woman with superficial invasion and multiple inguinal nodal metastases.
Collapse
|
15
|
Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P, Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71:2455-65. [PMID: 21459803 DOI: 10.1158/0008-5472.can-10-3323] [Citation(s) in RCA: 715] [Impact Index Per Article: 55.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Early local tumor invasion in breast cancer results in a likely encounter between cancer cells and mature adipocytes, but the role of these fat cells in tumor progression remains unclear. We show that murine and human tumor cells cocultivated with mature adipocytes exhibit increased invasive capacities in vitro and in vivo, using an original two-dimensional coculture system. Likewise, adipocytes cultivated with cancer cells also exhibit an altered phenotype in terms of delipidation and decreased adipocyte markers associated with the occurrence of an activated state characterized by overexpression of proteases, including matrix metalloproteinase-11, and proinflammatory cytokines [interleukin (IL)-6, IL-1β]. In the case of IL-6, we show that it plays a key role in the acquired proinvasive effect by tumor cells. Equally important, we confirm the presence of these modified adipocytes in human breast tumors by immunohistochemistry and quantitative PCR. Interestingly, the tumors of larger size and/or with lymph nodes involvement exhibit the higher levels of IL-6 in tumor surrounding adipocytes. Collectively, all our data provide in vitro and in vivo evidence that (i) invasive cancer cells dramatically impact surrounding adipocytes; (ii) peritumoral adipocytes exhibit a modified phenotype and specific biological features sufficient to be named cancer-associated adipocytes (CAA); and (iii) CAAs modify the cancer cell characteristics/phenotype leading to a more aggressive behavior. Our results strongly support the innovative concept that adipocytes participate in a highly complex vicious cycle orchestrated by cancer cells to promote tumor progression that might be amplified in obese patients.
Collapse
|
16
|
Persechini ML, Motton S, Leguevaque P, Donadille F, Escourrou G, Vierasu B, Hamdi S, Bennet A, Caron P. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour. Gynecol Endocrinol 2011; 27:345-50. [PMID: 20569103 DOI: 10.3109/09513590.2010.492883] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Ovarian Sertoli-Leydig cell tumours (SLCT), also termed arrhenoblastomas, are the most frequent virilising tumours in women of reproductive age. Very rare secretory Brenner tumours (BT) have been described, generally after the menopause. A 31-year-old woman sought medical advice for secondary amenorrhoea, progressive hirsutism and a 5-year history of virilisation syndrome with clitoromegaly. Testosterone was markedly high (285 ng/dl, N<85) with moderate elevation of delta 4-androstenedione (D4AD) (311 ng/dl, N <270), dehydroepiandrosterone sulfate (DHEAS) (366 μg/dl, N <340) and 17-hydroxyprogesterone (17OHP) (275 ng/dl). LH was 9 IU/l, FSH 4.3 IU/l, estradiol 60 pg/ml and progesterone 314 ng/100 ml. Cortisol was decreased (1.3 μg/dl) after the dexamethasone suppression test. Pelvic MRI showed a 5-cm right ovarian tumour with a 2.5 cm nodular component and cystic areas, and two nodules measuring 11 mm and 15 mm above the right and left ovaries. After right ovariectomy by laparoscopy, pathological examination concluded on a 3-cm SLCT and a 2-cm BT; the nodules above the ovaries were dysembryoplastic cysts. Postoperatively, testosterone level was normal after 24 h (26 ng/dl), estradiol and progesterone rapidly decreased, cyclic secretion then resumed and the patient menstruated at day 27. To our knowledge, this is the first report of an ovarian tumour associating a Sertoli-Leydig cell tumour and a Brenner tumour in a patient with virilisation syndrome which resolved after ovariectomy.
Collapse
Affiliation(s)
- Marie-Laure Persechini
- Service d'Endocrinologie et Maladies Métaboliques, Centre Hospitalier Universitaire Larrey, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Bochet L, Dauvillier S, Dirat B, Dabek M, Gonidec SL, Mari PO, Escourrou G, Valet P, Muller C. Abstract 511: Adipocyte-derived fibroblasts contribute to the desmoplastic reaction in breast cancer: A new link between breast cancer and obesity. Cancer Res 2011. [DOI: 10.1158/1538-7445.am2011-511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Now, it is widely established that malignant tumors, not merely grow into a preexisting interstitial tissue, but they actively form a new stroma and modify their composition. Accordingly, one of the features of many carcinomas, particularly breast, is the presence of a dense collagenous stroma, the so-called desmoplastic response, comprising fibroblast-like cells which play a crucial role in tumor progression. Peritumoral fibroblasts are composed of several subpopulations that are morphologically undistinguishable and their origins remain debated. Our results suggest that a part of this fibroblast could arise from the “reorientation” of mature adipocytes, highly represented in breast tumour microenvironment. Using an original 2D coculture system, we show that mature adipocytes cocultivated with breast tumour cells for 3 to 8 days lose their lipid content as well as their adipocyte differentiation markers (HSL, Adipsin, Adiponectin, C/EBPα, PPARγ, Resistin). This process is associated with intense morphological and functional changes leading to an activated fibroblast phenotype (exhibition of actin stress fibers, increase of focal adhesion sites). In this way, we have identified for the first time a new fibroblastic population called Adipocyte Derived Fibroblast (ADF). Interestingly, the reorientation occur in vivo since the injection of far red fluorescent tumour cells into a mice fatpad containing GFP-expressing adipocytes induce the apparition of GFP-fibroblast-like cells that interdigitate with tumour cells. Moreover, our results show that the ADF phenotype depends on the reactivation of the Wnt/β-catenin pathway. Finally, ADFs exhibit an increase of migratory and invasive abilities, with enhanced profibrotic secretions (fibronectin and collagen 1) suggesting that these cells could be key players in desmoplastic reaction. Ongoing experiments are performed to assess the presence of ADFs in breast human tumors. Our results might provide an explanation for the poor prognosis observed in localized breast cancer in obese women, since the nature of the desmoplastic reaction and the secretion pattern of ADF might be profoundly altered in this physiopathogical condition.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 511. doi:10.1158/1538-7445.AM2011-511
Collapse
Affiliation(s)
- Ludivine Bochet
- 1Team Microenvironment, Cancer and Adipocytes (MICA) Institute of Pharmacology and Structural Biology, IPBS, CNRS UMR 5089, Toulouse, France
| | - Stéphanie Dauvillier
- 1Team Microenvironment, Cancer and Adipocytes (MICA) Institute of Pharmacology and Structural Biology, IPBS, CNRS UMR 5089, Toulouse, France
| | - Béatrice Dirat
- 1Team Microenvironment, Cancer and Adipocytes (MICA) Institute of Pharmacology and Structural Biology, IPBS, CNRS UMR 5089, Toulouse, France
| | - Marta Dabek
- 1Team Microenvironment, Cancer and Adipocytes (MICA) Institute of Pharmacology and Structural Biology, IPBS, CNRS UMR 5089, Toulouse, France
| | | | | | | | | | - Catherine Muller
- 1Team Microenvironment, Cancer and Adipocytes (MICA) Institute of Pharmacology and Structural Biology, IPBS, CNRS UMR 5089, Toulouse, France
| |
Collapse
|
18
|
Vaysse C, Escourrou G, Motton S, Garrido I, Hoff J, Leguevaque P. Tumeur fibreuse solitaire de la vulve : à propos d’un cas. ACTA ACUST UNITED AC 2011; 39:e49-51. [DOI: 10.1016/j.gyobfe.2010.08.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2009] [Accepted: 04/05/2010] [Indexed: 10/18/2022]
|
19
|
Bochet L, Dirat B, Dauvillier S, Dabek M, Le Gonidec S, Mari P, Escourrou G, Roubeix C, Valet P, Muller C. R7: Les fibroblastes dérivés des adipocytes : de nouveaux acteurs de la réaction desmoplastique ? Bull Cancer 2010. [DOI: 10.1016/s0007-4551(15)30924-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Leguevaque P, Motton S, Decharme A, Soulé-Tholy M, Escourrou G, Hoff J. Predictors of recurrence in high-grade cervical lesions and a plan of management. Eur J Surg Oncol 2010; 36:1073-9. [PMID: 20870375 DOI: 10.1016/j.ejso.2010.08.135] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2009] [Revised: 07/21/2010] [Accepted: 08/19/2010] [Indexed: 10/19/2022] Open
Abstract
UNLABELLED PRÉCIS: Positive endocervical margins are an important predictor of recurrence in high-grade cervical lesions, and though they do not always warrant retreatment, closer surveillance is recommended. OBJECTIVE To identify predictors of recurrence and persistence of high-grade cervical dysplasia and to determine appropriate follow-up. DESIGN prospective pilot study. SETTING Gynaecological surgical center. POPULATION Three hundred fifty-two patients were treated between 1999 and 2002 for high-grade lesions. METHODS According to the accessibility of the transformation zone and the degree of dysplasia, patients were treated either by conization or by loop electrosurgical excision procedure (LEEP). Follow-up comprised colposcopy and Pap-smear screening 4-6 months after treatment as well as high-risk human papillomavirus (HR-HPV) testing before and after treatment. MAIN OUTCOME MEASURES underscore predictors of recurrence and propose a treatment flowchart for both management and follow-up. RESULTS Of the 352 patients, 37 (10.5%) had true recurrence 6 months after initial surgical treatment and 6 patients (1.7%) had persistent lesions. Overall, 43 patients (12.2%) were considered as having recurrent disease. Patients were followed up for 5 years with a mean of 73 months. The most important predictor of recurrence was a positive HR-HPV test at 6 months postoperatively (odds ratio 38.8, 95% confidence interval 14.09, 107.05). The second significant predictor was positive endocervical margins and the third was positive pre-treatment HPV typing. A positive post-treatment HPV test had a more significant influence on risk than a positive test before treatment. CONCLUSION In agreement with recent findings, our study supports the usefulness of the HR-HPV test in the follow-up of treated high-grade lesions, especially when excision margins were positive.
Collapse
Affiliation(s)
- P Leguevaque
- Department of General and Gynecological Surgery, CHU Rangueil, Toulouse, France
| | | | | | | | | | | |
Collapse
|
21
|
Moskovitch G, Chabbert V, Escourrou G, Desloques L, Otal P, Glock Y, Rousseau H. Tumeurs cardiaques : aspects en scanner et en IRM. ACTA ACUST UNITED AC 2010; 91:857-77. [DOI: 10.1016/s0221-0363(10)70128-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
22
|
Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Le Gonidec S, Escourrou G, Valet P, Muller C. 495 Cancer-associated adipocytes exhibit an activated phenotype and contribute to early breast cancer invasion in vitro and in vivo. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)71296-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
23
|
Dirat BA, Bochet L, Escourrou G, Valet P, Muller C. Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 2010; 19:45-52. [PMID: 20551667 DOI: 10.1159/000316896] [Citation(s) in RCA: 78] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
In addition to diabetes and cardiovascular diseases, epidemiological evidence demonstrates that people who are obese or overweight are at increased risk of developing cancer - colon, breast (in postmenopausal women), endometrial or kidney cancer being among the most frequent. In addition to the increase in tumor occurrence, obesity also affects tumor prognosis, especially in breast and prostate cancers. In breast cancer, obesity is associated with reduced survival and increased recurrence independent of menopausal status. Host factors seem to contribute to the occurrence of tumors exhibiting an aggressive biology defined by advanced stages and high grade. Mature adipocytes are part of the breast cancer tissue and as highly endocrine cells susceptible to profoundly modify breast cancer cell behavior. Tumor progression has recently been recognized as the product of an evolving crosstalk between tumor cells and the surrounding 'normal' cells. We propose that such a bidirectional crosstalk exists between breast cancer cells and tumor-surrounding adipocytes, and that the tumor-modified adipocytes (or cancer-associated adipocytes) are key actors in tumor progression. The positive contribution of cancer-associated adipocytes into tumor progression might be amplified in obese women and explains at least in part the poor prognosis observed in this subset of patients.
Collapse
|
24
|
Penault-Llorca F, Lannes B, Vincent-Salomon A, MacGrogan G, Vilain M, Fermeaux V, Treilleux I, Blanc-Fournier C, Leroux A, Antoine M, Ettore F, Charpin C, Jacquemier J, Escourrou G, Lacroix-Triki M, Gosset P, Sagan C, Arnould L, Couturier J. Fluorescence in situ hybridization (FISH) technique by reference centers for HER2 status determination in metastatic breast cancer: quality assurance results of FISH 2002 study. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-2069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Abstract #2069
Background: Concordance between IHC and FISH in local and regional centers was evaluated in the FISH 2002 Study. Primary metastatic breast cancer (MBC) tumor samples were tested by IHC for HER2 status according to in-house techniques at 18 regional (n=871) and 81 peripheral (n=670) centers in France between 2002 and 2006. All samples were tested by FISH at regional centers [Penault-Llorca et al. SABCS 2006]. This second part of the study comprises quality assurance evaluation of FISH techniques.
 Methods: 464 cases were selected according to the protocol and were either re-assessed using archived pictures or retested by 3 reference centers (Clermont-Ferrand, Strasbourg, Paris-Curie). 246 samples were re-assessed and 166 were retested.
 Results:Global discordance combining re-assessment and retesting results was 10.7% in the first half of the study and 5.1% in the second part (p=0.041).
 
 Discussion: Concordance was excellent for negative (100%) and IHC 2+ cases (97%). Among low amplification cases (≥6 and <8 copies), 70% were concordant: discordant cases were mainly interpretation pitfalls of polysomic cases, emphasizing the importance of double-stained FISH analyses. These quality assurance results demonstrate that overall concordance and quality of HER2 status determined by FISH has improved significantly over time. This improvement is likely to be related to introduction of rigorous quality control procedures, training, and education, all of which should be continued.
Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 2069.
Collapse
Affiliation(s)
| | - B Lannes
- 14 Hopitaux Universitaires de Strasbourg, Strasbourg, France
| | | | | | - M Vilain
- 4 Centre Oscar Lambret, CLCC de la Région Nord, Lille, France
| | | | | | | | - A Leroux
- 7 Centre Alexis Vautrin, Vandoeuvre Nancy, France
| | - M Antoine
- 8 Hôpital Tenon APHP, Paris, France
| | - F Ettore
- 16 Centre Antoine Lacassagne, Nice, France
| | - C Charpin
- 9 CHU AP-HM Faculté de Médicine, Marseille, France
| | - J Jacquemier
- 10 Institut Paoli Calmettes Cancer Institute, Marseille, France
| | | | | | - P Gosset
- 11 GHICL-FLM Hopital St Vincent, Lille, France
| | - C Sagan
- 12 Hôpital Nord Laënec, Nantes, France
| | - L Arnould
- 13 Centre G-F Leclerc, Dijon, France
| | | |
Collapse
|
25
|
Gamé X, Allard J, Escourrou G, Gourdy P, Tack I, Rischmann P, Arnal JF, Malavaud B. Estradiol increases urethral tone through the local inhibition of neuronal nitric oxide synthase expression. Am J Physiol Regul Integr Comp Physiol 2008; 294:R851-7. [DOI: 10.1152/ajpregu.00467.2007] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Estrogens are known to modulate lower urinary tract (LUT) trophicity and neuronal nitric oxide synthase (nNOS) expression in several organs. The aim of this study was to explore the effects of endogenous and supraestrus levels of 17β-estradiol (E2) on LUT and urethral nNOS expression and function. LUT function and histology and urethral nNOS expression were studied in adult female mice subjected either to sham surgery, surgical castration, or castration plus chronic E2 supplementation (80 μg·kg−1·day−1, i.e., pregnancy level). The micturition pattern was profoundly altered by long-term supraestrus levels of E2 with decreased frequency paralleled by increased residual volumes higher than those of ovariectomized mice. Urethral resistance was increased twofold in E2-treated mice, with no structural changes in urethra, supporting a pure tonic mechanism. Acute nNOS inhibition by 7-nitroindazole decreased frequency and increased residual volumes in ovariectomized mice but had no additive effect on the micturition pattern of long-term supraestrus mice, showing that long-term supraestrus E2 levels and acute inhibition of nNOS activity had similar functional effects. Finally, E2 decreased urethral nNOS expression in ovariectomized mice. Long-term supraestrus levels of E2 increased urethral tone through inhibition of nNOS expression, whereas physiological levels of E2 had no effect.
Collapse
|
26
|
Le Guellec S, Malavaud B, Quintyn M, Escourrou G, Delisle M, Plante P, Rischmann P, Soulié M, Mazerolles C. Les micro-foyers d’adénocarcinome prostatique sur biopsies : corrélations entre la taille du foyer et les caractéristiques tumorales après prostatectomie radicale. Ann Pathol 2006. [DOI: 10.1016/s0242-6498(06)78402-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Benit A, Allard J, Rimailho J, Fauvel J, Escourrou G, Vezzosi D, Donadille F, Bennet A, Caron P. Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels. J Endocrinol Invest 2006; 29:443-9. [PMID: 16794368 DOI: 10.1007/bf03344128] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To evaluate the role of PTH-related peptide (PTH-rP) and 1,25-dihyhydroxyvitamin D3 in a case of hypercalcemia related to an ovarian adenocarcinoma. DESIGN We report a case of humoral hypercalcemia in a patient aged 74 yr with a clear cell adenocarcinoma of the right ovary at an early stage of its development (stage T1aN0M0) revealed by moderate and persistent hypercalcemia (variable level between 2.7 and 3.2 mmol/l without any treatment) over six months. METHODS PTH-rP and 1,25-dihydroxyvitamin D3 were measured in blood samples taken before and after hysterectomy and bilateral salpingooophorectomy and in blood samples taken intraoperatively from the right ovarian vein and a peripheral vein. RESULTS High levels of plasma PTH-rP and 1,25-dihydroxyvitamin D3 concomitant with high serum calcium and low PTH levels were found before surgery, which was followed by normalisation of all parameters studied. A concentration gradient was found regarding plasma PTHrP (right ovarian vein 60.4 pmol/l, peripheral vein 4.5 pmol/l), not 1,25-dihydroxyvitamin D3. CONCLUSION 1) moderate and persistent hypercalcemia can be observed at an early stage of an ovarian carcinoma; 2) the gradient of PTH-rP concentration between the samples taken from the right ovarian vein and a peripheral vein provides evidence for a direct secretion of PTH-rP by the ovarian tumor; 3) the increased 1,25-dihydroxyvitamin D3 level is not related to a direct ovarian production, but is a consequence of PTH-rP secretion.
Collapse
Affiliation(s)
- A Benit
- Service d'Endocrinologie, Hôpital Rangueil, CHU Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Vezzosi D, Bouisson M, Escourrou G, Laurell H, Selves J, Seguin P, Pradayrol L, Caron P, Buscail L. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours. Clin Endocrinol (Oxf) 2006; 64:63-7. [PMID: 16402930 DOI: 10.1111/j.1365-2265.2005.02417.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE The distinction between benign and malignant well-differentiated endocrine tumours is hard to achieve. The aim of the present study was to determine whether detection of telomerase or quantification of human telomerase reverse transcriptase protein subunit (hTERT) differ between benign and malignant endocrine tumours. PATIENTS AND METHODS This retrospective study investigated 31 well-differentiated primary endocrine tumours. Based on clinical and histopathological criteria, tumours were categorized with the most recent WHO classification as 'benign' (n = 14), 'uncertain' (n = 5) or 'malignant' (n = 12) with (n = 7) or without (n = 5) metastasis after a mean follow-up of 40.4 +/- 25.8 months (4-122 months). All these tumours were assayed for telomerase activity and hTERT mRNA expression [real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)]. RESULTS Telomerase activity was detected in 7 malignant and metastatic tumours, in 1 malignant tumour without metastases, in 1 uncertain tumour and in 1 benign tumour. hTERT mRNA levels were significantly higher in malignant endocrine tumours with or without metastases (P = 0.001) when compared to benign tumours. The negative predictive value of hTERT mRNA quantification for the diagnosis of malignancy was 88.9%, whereas the positive predictive value was 68.7%. CONCLUSION The presence of telomerase activity within the primary endocrine tumour might indicate a malignant tumour and might suggest the need for an attentive search for concomitant metastases. Quantification of hTERT mRNA could be used in clinical practice to exclude malignancy in most endocrine tumours.
Collapse
Affiliation(s)
- Delphine Vezzosi
- Institut National de la Santé et de la Recherche Médicale Unit 531, Institut Louis Bugnard IFR31, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Abstract
PURPOSE We evaluated the prevalence of carcinoma in situ (CIS) in orchiectomy specimens performed for germ cell tumors smaller than 40 mm in diameter to propose an appropriate conservative approach to bilateral tumors or tumor of a solitary testis. MATERIALS AND METHODS Of 127 patients treated with orchiectomy between 1990 and 2002, 41 who presented with a tumor of less than 40 mm in diameter were selected for histological analysis of testicular parenchyma. The morphological items assessed were CIS, spermatogenesis and Leydig cell hyperplasia. RESULTS CIS was observed in 39 of the 41 patients (95%). CIS was evenly distributed throughout the testicular parenchyma (ie around and beyond the tumor) in all 39 cases. Spermatogenesis was observed in 12 of 41 specimens (29%), spermatogenesis without spermatozoa was noted in 14 (34%) and absent germ cells were found in 15 (37%). Leydig cell hyperplasia was observed in 24 cases (58%). CONCLUSIONS Histological analysis of whole orchiectomy specimens showed that CIS is almost always present in testicular parenchyma adjacent to germ cell tumor. In bilateral testis cancer or cancer occurring in a solitary testis tumorectomy plus radiotherapy appears to be the appropriate treatment in patients with a small tumor and no other risk factors. In patients who wish to father a child and have preserved spermatogenesis the natural history of CIS allows the postponement of testicular radiotherapy after orchiectomy, giving the double advantage of preserving testicular endocrine function and maintaining the possibility of natural fatherhood.
Collapse
Affiliation(s)
- Eric Huyghe
- Human Fertility Research Group, Paule de Viguier Hospital, Urological Surgery and Andrology Department, Rangueil Hospital, Toulouse, France
| | | | | | | | | | | |
Collapse
|
30
|
Kunduzova OR, Escourrou G, De La Farge F, Salvayre R, Séguélas MH, Leducq N, Bono F, Herbert JM, Parini A. Involvement of Peripheral Benzodiazepine Receptor in the Oxidative Stress, Death-Signaling Pathways, and Renal Injury Induced by Ischemia-Reperfusion. J Am Soc Nephrol 2004; 15:2152-60. [PMID: 15284300 DOI: 10.1097/01.asn.0000133563.41148.74] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
The peripheral benzodiazepine receptor (PBR) is a critical component of the mitochondrial permeability transition pore, which is involved in the regulation of cell death. In the present study we investigated the role of PBR in the regulation of signaling pathways leading to apoptotic and necrotic damage and renal dysfunction in a rat model of ischemia-reperfusion. Renal ischemia-reperfusion led to extended tubular apoptosis and necrosis that were associated with peroxidative damage, high levels of proapoptotic Bax expression, and low levels of antiapoptotic Bcl-2 expression, cleavage of death substrate, poly(ADP-ribose) polymerase (PARP), and activation of a key effector of apoptosis, caspase-3. Rat pretreatment with a novel PBR antagonist, SSR180575, significantly decreased postreperfusion oxidative stress and tubular apoptosis and necrosis. This effect was associated with inhibition of caspase-3 activation and PARP cleavage, upregulation of Bcl-2, and downregulation of Bax. Furthermore, inhibition of PBR accelerated the recovery of normal renal function, as assessed by measurement of levels of plasma creatinine and blood urea nitrogen. These findings reveal a role for PBR as a modulator of necrotic and apoptotic cell death induced by ischemia-reperfusion and suggest that regulation of PBR may provide new therapeutic implications for the prevention of acute renal failure.
Collapse
Affiliation(s)
- Oxana R Kunduzova
- INSERM U388, Institut Louis Bugnard, CHU Rangueil, Bat. L3, 31403 Toulouse Cedex 4, France
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Affiliation(s)
- C Pienkowski
- Unité d'Endocrinologie, Génétique et Gynécologie Médicale, Hôpital des Enfants, Toulouse, France.
| | | | | | | | | | | | | |
Collapse
|
32
|
Gamé X, Soulié M, Moussouni S, Roux D, Escourrou G, Chevreau C, Aziza R. Renal angiomyolipoma associated with rapid enlargement [correction of enlargment] and inferior vena caval tumor thrombus. J Urol 2003; 170:918-9. [PMID: 12913732 DOI: 10.1097/01.ju.0000074709.64318.5c] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Xavier Gamé
- Department of Urology, Division of Urological Surgery and Andrology, Rangueil University Hospital, 31403 Toulouse Cedex 4, France
| | | | | | | | | | | | | |
Collapse
|
33
|
Kunduzova OR, Escourrou G, Seguelas MH, Delagrange P, De La Farge F, Cambon C, Parini A. Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 2003; 17:872-4. [PMID: 12670883 DOI: 10.1096/fj.02-0504fje] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
The pineal hormone melatonin has been reported to protect tissue from oxidative damage. This study was designed to determine whether melatonin could prevent cell events leading to tissue injury and renal dysfunction after ischemia/reperfusion (I/R). Using an in vivo rat model of I/R, we show a significant increase in kidney malondialdehyde concentrations, reflecting lipid peroxidation, and cell apoptosis measured by TUNEL staining. This apoptotic cell death was associated with an increase in the activity of the proapoptotic factor caspase-3, determined by fluorometric protease activity assay. Histomorphological analysis of ischemic kidneys revealed that the most extensive tubular necrosis occurred at 24 and 48 h after reperfusion, which correlated with peak elevations in blood urea nitrogen and creatinine. Rat pretreatment with melatonin prevented lipid peroxidation, cell apoptosis, and necrosis and blocked caspase-3 activity. The prevention of tissue injury was associated with the improvement of renal function as shown by the decrease in blood urea nitrogen and creatinine concentrations. The demonstration that melatonin prevents postreperfusion apoptotic and necrotic cell death and improves renal function suggests that melatonin may represent a novel therapeutic approach for prevention of I/R injury.
Collapse
Affiliation(s)
- Oxana R Kunduzova
- INSERM U388, Institut Louis Bugnard, CHU Rangueil, Bat. L3, 31403 Toulouse Cedex 4, France
| | | | | | | | | | | | | |
Collapse
|
34
|
Lacoste-Collin L, Gomez-Brouchet A, Escourrou G, Delisle MB, Levade T, Uro-Coste E. Expression of p27(Kip1) in bladder cancers: immunohistochemical study and prognostic value in a series of 95 cases. Cancer Lett 2002; 186:115-20. [PMID: 12183083 DOI: 10.1016/s0304-3835(02)00319-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Prognostic value of p27(Kip1) immunohistochemical expression was evaluated in a series of 95 bladder carcinomas. Low p27(Kip1) expression was correlated with higher tumor grade (P=0.01) and stage (P=0.009), associated with poor overall survival (P=0.01) and, for superficial cancers, with disease-free survival (P=0.05). Thirty-five cases exhibited a heterogeneous expression related in some instances to tumoral architecture. Seventeen cases showed a cytoplasmic reactivity related to low nuclear expression (P=0.057). Loss of p27(Kip1) expression is a pejorative event in bladder tumors and inhibition of p27(Kip1) degradation could offer new therapeutic ways.
Collapse
|
35
|
Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A, Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 2002; 16:1129-31. [PMID: 12039844 DOI: 10.1096/fj.01-1008fje] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Reactive oxygen species (ROS) contribute to the ischemia-reperfusion injury. In kidney, the intracellular sources of ROS during ischemia-reperfusion are still unclear. In the present study, we investigated the role of the catecholamine-degrading enzyme monoamine oxidases (MAOs) in hydrogen peroxide (H2O2) generation after reperfusion and their involvement in cell events leading to tissue injury and recovery. In a rat model of renal ischemia-reperfusion, we show concomitant MAO-dependent H2O2 production and lipid peroxidation in the early reperfusion period. Rat pretreatment with the irreversible MAO inhibitor pargyline resulted in the following: i) prevented H2O2 production and lipid peroxidation; ii) decreased tubular cell apoptosis and necrosis, measured by TUNEL staining and histomorphological criteria; and iii) increased tubular cell proliferation as determined by proliferating cell nuclear antigen expression. MAO inhibition also prevented Jun N-terminal kinase phosphorylation and promoted extracellular signal-regulated kinase activation, two mitogen-activated protein kinases described as a part of a "death" and "survival" pathway after ischemia-reperfusion. This work demonstrates the crucial role of MAOs in mediating the production of injurious ROS, which contribute to acute apoptotic and necrotic cell death induced by renal ischemia-reperfusion in vivo. Targeted inhibition of these oxidases could provide a new avenue for therapy to prevent renal damage and promote renal recovery after ischemia-reperfusion.
Collapse
Affiliation(s)
- Oxana R Kunduzova
- INSERM U388, IFR31, Institut Louis Bugnard, CHU Rangueil, Toulouse 31403 Cedex 4, France
| | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
The anatomy and histological structure of the proximal (PPUL), distal (DPUL) and intermediate (IPUL) pubourethral ligaments in women was examined to improve the understanding of their roles in female urethral physiology. An anatomical study of the pelvis was carried out in 10 adult female cadavers (60-102 years), the pelvis being removed and frozen prior to dissection. The pubourethral ligaments (PUL) were dissected in sagittal sections in seven specimens and in a frontal section in one specimen; the remaining two pelves were dissected using a hypogastric approach. The location, insertion, direction and histological structure of the ligamentous structures were studied. The PUL were identified in all 10 dissections, being paired, symmetrical, pearly-white, fibrous and resistant to stretching. The bony (parietal) insertion was variable on the posterior surface of the pubis, while the visceral insertion was located on the dorsal aspect of the proximal third of the urethra and neck of the bladder for the PPUL and on the distal third of the urethra for the DPUL. Histologically, the ligaments were composed of dense collagen fibres and bundles of axially orientated smooth muscle fibres. The PPUL was closely associated with the sphincter urogenitalis muscle, whereas the DPUL appeared to reinforce the role of the compressor urethra. It is suggested that the PUL plays an effective role in passive and active suspension of the urethra. The pubourethral ligaments are a constant anatomical entity which should be spared in urethral surgery in women in order to ensure an intact urogenital sphincter.
Collapse
Affiliation(s)
- N Vazzoler
- Department of Urologic Surgery, University Hospital of Rangueil, Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
37
|
Aziza R, Soulié M, Escourrou G, Bachaud J, Molinié L, Tollon C, Joffre F, Plante P. [Local staging of prostate carcinoma with phased array MR imaging: prospective study over 5 years]. J Radiol 2002; 83:39-44. [PMID: 11965148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
PURPOSE To assess by MRI, using a pelvic phased array coil, the accuracy for staging prostate carcinoma and to correlate the results with the rate of positive surgical margins. MATERIALS AND METHODS Between January 1995 and December 1999, 176 patients with localized prostate carcinoma underwent a preoperative MRI examination using a pelvic phased-array coil (1 Tesla). MRI and histological results were compared in a prospective study. RESULTS 131 were classified T2 and 45 were classified T3 at MRI. Pathologic findings showed 103 pT2 and 73 pT3. The accuracy of MRI (extra capsular or vesicle extension) was 75%. The risk for a patient labelled T2 or T3 at MRI to have a positive surgical margin was respectively 13.7% and 31%. CONCLUSION This study shows that the phased-array coil has a low sensitivity but a good specificity to distinguish between organ-confined cancer or not. It shows that the risk of positive surgical margins is higher for T3 lesions at MRI. The low sensitivity should be improved by using a multi coil phased array.
Collapse
Affiliation(s)
- R Aziza
- Institut Claudius Regaud. 20, rue du Pont Saint Pierre, 31052 Toulouse, France
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Gomez-Brouchet A, Soulie M, Delisle MB, Escourrou G. Mesenchymal chondrosarcoma of the kidney. J Urol 2001; 166:2305. [PMID: 11696762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Affiliation(s)
- A Gomez-Brouchet
- Department of Pathology, University Hospital of Rangueil, Toulouse, France
| | | | | | | |
Collapse
|
39
|
Astudillo L, Dahan S, Escourrou G, Sailler L, Carreiro M, Ollier S, Arlet P. Cat scratch responsible for primary cutaneous Nocardia asteroides in an immunocompetent patient. Br J Dermatol 2001; 145:684-5. [PMID: 11703311 DOI: 10.1046/j.1365-2133.2001.04447.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
40
|
Soulié M, Seguin P, Benoit J, Escourrou G, Tollon C, Vazzoler N, Pontonnier F, Plante P. Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients. Urology 2001; 58:217-21. [PMID: 11489704 DOI: 10.1016/s0090-4295(01)01167-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
OBJECTIVES To assess the impact of a modified technique of apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins (PSMs). METHODS Between 1992 and 1998, 212 nonconsecutive patients with localized prostate cancer (57 T1, 155 T2) underwent radical retropubic prostatectomy and were divided into two groups: group 1, 85 patients who underwent surgery before January 1994; and group 2, 127 patients who underwent surgery with the modification of the apical dissection after January 1994. The modified technique consisted of a wide excision of periprostatic soft tissue at the apex, including the bilateral neurovascular bundles. The clinical data (age, prostate-specific antigen, clinical staging) and pathologic findings (pathologic staging, Gleason score, PSM rate) of the two groups were compared. RESULTS No significant difference was found between the two groups regarding the median prostate-specific antigen level (10.8 ng/mL and 9.5 ng/mL), Gleason score, and pathologic staging. Overall, the PSM rate was 53% in group 1 and 20.5% in group 2 (P <0.001). The number of PSMs decreased 2.6-fold in group 2. The PSM rate was significantly reduced at the apex with the new technique (group 1, 33.3%; group 2, 7.7%; P = 0.008). The PSM rate expressed with the odds ratio was 4.4-fold lower for patients in group 2 than for those in group 1. CONCLUSIONS The modified apical dissection in radical retropubic prostatectomy significantly improves the PSM rate in patients with localized T1-T2 prostate cancer.
Collapse
Affiliation(s)
- M Soulié
- Department of Urologic Surgery, Rangueil University Hospital, Toulouse, France
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Soulié M, Aziza R, Escourrou G, Seguin P, Tollon C, Molinier L, Bachaud J, Joffre F, Plante P. Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study. Urology 2001; 58:228-32. [PMID: 11489708 DOI: 10.1016/s0090-4295(01)01113-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
OBJECTIVES We assessed magnetic resonance imaging (MRI) performance in the prediction of positive surgical margins (PSMs) before radical prostatectomy in a prospective study correlating the MRI results and pathologic findings. METHODS Between January 1995 and December 1999, 176 patients (mean age 64.2 years, range 49 to 75), with localized prostate cancer (49 with Stage T1 and 127 with Stage T2) underwent preoperative MRI with a pelvic phased-array coil (Tesla-1, Siemens) at a mean interval of 35 days after randomized transrectal biopsies. The mean preoperative prostate-specific antigen level was 10.9 ng/mL (range 1.2 to 39). The MRI studies and specimen analysis were performed by one radiologist unaware of the clinical and biopsy findings and by one pathologist, respectively. Multivariate analysis was performed to compare the predictive value of MRI staging, prostate-specific antigen value, and preoperative Gleason score to identify the PSM rate. RESULTS Of the 176 patients, 131 (74%) had Stage T2 disease by MRI and 45 (26%) Stage T3 disease by MRI. Pathologic staging showed 103 with pT2 and 73 with pT3. Overall, the PSM rate of the series was 18%. The PSM rate was 13.7% and 31% for patients with T2 and T3 disease by MRI, respectively. For the T3 MRI cases, the PSM rate was 2.32-fold higher. MRI staging, like the prostate-specific antigen value, was a predictive factor of PSMs (P = 0.05). CONCLUSIONS The results of this study show that preoperative MRI staging with the phased-array coil may be helpful in predicting the PSM risk in radical prostatectomy candidates with clinically localized prostate cancer.
Collapse
Affiliation(s)
- M Soulié
- Department of Urology, Rangueil University Hospital, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Soulie M, Connan L, Escourrou G, Seguin P, Pontonnier F, Plante P. [Leiomyosarcoma of the renal vein]. Prog Urol 2001; 11:502-6. [PMID: 11512465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
The authors report a new case of leiomyosarcoma of the right renal vein, marked by a rapidly fatal course within 9 months, despite the initial absence of metastasis. This exceptional vascular tumour (only about thirty cases have been published) must be distinguished from primary renal leiomyosarcoma and retroperitoneal leiomyosarcomas involving adjacent structures. This difficult diagnosis was suggested by preoperative CT and angiography. Leiomyosarcomas of the renal vein generally have an unfavourable outcome in the medium term. The prognosis is related to the localized nature of the tumour and the risk of local and distant recurrence. Limited tumour resection is rarely sufficient and radical nephrectomy is usually necessary, possibly associated with a vascular procedure on the inferior vena cava in the case of contiguous extension.
Collapse
Affiliation(s)
- M Soulie
- Service de Chirurgie Urologique et d'Andrologie, CHU de Rangueil, 31043 Toulouse.
| | | | | | | | | | | |
Collapse
|
43
|
Soulié M, Escourrou G, Vazzoler N, Seguin P, Suc B, Pontonnier F, Plante P. [Primary carcinoid tumor and horseshoe kidney: potential association]. Prog Urol 2001; 11:301-3. [PMID: 11400494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
The authors present the ninth case of primary carcinoid tumour arising in a horseshoe kidney. The diagnosis and treatment were delayed due to the benign cystic appearance of the initial lesion. This exceptional association must be kept in mind, as horseshoe kidney is associated with an increased risk of malignant tumours, especially for carcinoid tumours. The minimally aggressive nature of these tumours generally allows limited surgical resection.
Collapse
Affiliation(s)
- M Soulié
- Service de Chirurgie Urologique et d'Andrologie, CHU de Rangueil, Toulouse, France.
| | | | | | | | | | | | | |
Collapse
|
44
|
Soulié M, Mouly P, Caron P, Seguin P, Vazzoler N, Escourrou G, Bastide T, Pontonnier F, Plante P. Retroperitoneal laparoscopic adrenalectomy: clinical experience in 52 procedures. Urology 2000; 56:921-5. [PMID: 11113731 DOI: 10.1016/s0090-4295(00)00834-7] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
OBJECTIVES Laparoscopic adrenalectomy has become an effective option for removal of small adrenal tumors. The aim of this prospective study was to evaluate the retroperitoneal approach with regard to intraoperative complications, morbidity, and length of hospital stay. METHODS Between September 1996 and October 1999, we performed 52 laparoscopic adrenalectomies (31 left, 21 right) for benign lesions by a retroperitoneal approach in 44 patients (27 women, 17 men) with a mean age of 46.9 years (range 17 to 74). The average adrenal tumor size was 32 mm (range 10 to 63). All procedures required four trocars and a mean operative time of 135 minutes (range 75 to 240). RESULTS There was no mortality, conversion rate to open surgery was 1.9%, and estimated blood loss was 80 mL (range 30 to 200). With a mean follow-up of 16 months, morbidity was 17.2%, which included intraoperative complications (5. 7%) with two vascular injuries, and postoperative complications (11. 5%) with wound infections, deep hematoma, and parietal dehiscence. Average length of hospital stay was 5 days with a mean analgesic consumption of 2 days (range 1 to 5). CONCLUSIONS The retroperitoneal approach in laparoscopic adrenalectomy appears to be a minimally invasive and safe therapeutic option that may become the standard for unilateral or bilateral adrenal tumors not larger than 7 cm. However, a learning curve in laparoscopy is indispensable before starting this type of procedure.
Collapse
Affiliation(s)
- M Soulié
- Department of Urology and Andrology, Hospital of Rangueil, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Game X, Soulié M, Escourrou G, Tollon C, Seguin P, Pontonnier F, Plante P. [Large-cell calcifying Sertoli cell tumors: apropos of a case and review of the literature]. Prog Urol 1999; 9:756-9. [PMID: 10555235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
The authors report the case of a 22-year-old man presenting with a tumour of the lower pole of the left testis, present for 4 months, which proved to be a calcified Sertoli large cell tumour, an extremely rare group of sex cord tumours of the testis presenting specific clinical and histological features. These tumours are usually benign, occur during the first two decades of life and can be associated with dysplastic complexes or endocrinopathies (Carney's complex, Peutz-Jeghers syndrome). They present either in the form of bilateral, multifocal tumours in the context of a pathological association, or in the unilateral form, without association. Several malignant forms with metastases have been described. Conventional treatment is transinguinal radical orchidectomy.
Collapse
Affiliation(s)
- X Game
- Service de Chirurgie Urologique et Andrologie, CHU de Rangueil, Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
46
|
Otal P, Escourrou G, Mazerolles C, Janne d'Othee B, Mezghani S, Musso S, Colombier D, Rousseau H, Joffre F. Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 1999; 19:569-81. [PMID: 10336189 DOI: 10.1148/radiographics.19.3.g99ma07569] [Citation(s) in RCA: 84] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Uncommon adrenal masses include cystic lesions (hydatid cyst, endothelial cyst), solid lesions (hemangioma, ganglioneuroma, angiosarcoma, primary malignant melanoma), and solid fatty lesions (myelolipoma, collision tumor). Most of these lesions do not have specific imaging features. The liquid content of adrenal cysts is clearly demonstrated on ultrasonographic scans, computed tomographic scans, and magnetic resonance images. Nevertheless, the histologic type cannot be predicted except at some stages of hydatid disease in which pathognomonic features are present. The most typical imaging features of hemangioma are phleboliths and enhancement of peripheral vascular lakes. Ganglioneuroma has nonspecific radiologic features, but this diagnosis should be considered in cases with early enhancement of fine septa and progressive filling. The radiologic features of angiosarcoma and primary malignant melanoma are nonspecific. A macroscopic lipid content within an adrenal mass is theoretically characteristic of myelolipoma. This diagnosis should be made with caution, especially when the lipid content is not predominant, because of the possible association with an adenoma.
Collapse
Affiliation(s)
- P Otal
- Department of Radiology, University Hospital Rangueil, Toulouse, France
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Huyghe E, Soulie M, Tollon C, Escourrou G, Pontonnier F, Plante P. [Value of free PSA/total PSA ratio in therapeutic decisions in the case of a single positive biopsy of the prostate]. Prog Urol 1999; 9:281-7. [PMID: 10370952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
OBJECTIVES Study of the value of the free PSA/total PSA ratio in the therapeutic decision concerning prostatic adenocarcinoma, in the case of a single positive biopsy. MATERIAL AND METHODS The free PSA/total PAS ratio was calculated on serum samples derived from 37 patients with clinically localized prostatic carcinoma and only one positive biopsy, in whom radical prostatectomy was performed. RESULTS The free PSA/total PSA ratio appeared to be independent of pathological stage and histological prognostic criteria (grade and score, degree of capsular effraction). CONCLUSION In the case of a single positive biopsy, calculation of the free PSA/total PSA ratio does not appear to provide any decisional criteria in favour of radical prostatectomy.
Collapse
Affiliation(s)
- E Huyghe
- Service de Chirurgie Urologique, CHU de Rangueil, Toulouse, France
| | | | | | | | | | | |
Collapse
|
48
|
Tollon C, Soulié M, Aziza R, Escourrou G, Pontonnier F, Plante P. [The use of MRI with a pelvic phased array antenna in the evaluation of the gland and tumor volume of clinically localized prostatic adenocarcinoma]. Prog Urol 1998; 8:223-31. [PMID: 9615932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
UNLABELLED Prostate cancer is clinically understaged in 50% of cases. It was improved with the use of random biopsies, PSA analysis (balanced and unbalanced) and Gleason grade on biopsies. Traditional imaging techniques such as endorectal ultrasonography and CT Scan are known to be of no interest. MRI is a non-evasive technique which allows the three dimensional study of an organ with a high quality of tissue contrast. Moreover, the positioning of surface antennae or "phased array" allowed improvement in spatial resolution. OBJECTIVE To determine whether MRI allows an accurate staging of clinically localised adenocarcinoma by the direct estimation of capsular effraction, measure of glandular and tumor volumes and finally by obtaining reliable PSAd. MATERIAL AND METHODS A prospective study was done from March 1995 to November 1996 on 55 patients with a clinically localised adenocarcinoma. MRI 1 Tesla Imager (SIEMENS), pelvic phased array antennae. FSE sequences (T1 and T2), axial and frontal. Evaluation of volumes by on-screen. Standford protocol for histo-pathologic reading on the axial cuts. Direct planimetry on a millimetre paper. RESULTS Reliable estimation of glandular volume (average difference 0.7 cc). Sub-evaluation of tumoral volume (average difference 1.04 cc) with a 30% margin of error, accuracy 87%. Tumoral stage exact in almost 90% of the cases with a PPV of 94%. CONCLUSION Prostatic MRI, using surface antennae, allows to complete the conventional stage by stage development by correctly diagnosing 75% of locally evolved stages. Its limits are linked to the nature of the signal of the tumorous tissue as to the localisation of neoplasic lesions.
Collapse
Affiliation(s)
- C Tollon
- Service de Chirurgie urologie et Andrologie, CHU Rangueil, Toulouse, France
| | | | | | | | | | | |
Collapse
|
49
|
Li GR, Soulie M, Escourrou G, Versini P, Pontonnier F, Plante P, Tostain J. [Renal oncocytoma. Report of 13 cases]. Ann Urol (Paris) 1997; 31:123-30. [PMID: 9273842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We report 13 cases of renal oncocytoma. Urinary symptoms occurred in only 3 cases. The patient's age ranged from 41 to 74 years with an average of 62.3 years. The mean tumor diameter was 5.6 cm (range: 1.5-14). Diagnostic features of ultrasonography, CT scan and, in some instances, angiography were suggestive of renal oncocytoma in 2 patients, but never affirmative, 4 patients were treated by partial nephrectomy. No local or metastatic recurrence was observed with a mean follow-up of 30.8 months, ranging from 6 to 96 months. We assume that the term renal oncocytoma should be restricted to tumors exclusively composed of regular oncocytic cells with an eosinophilic granular mitochondria-rich cytoplasm and an absence of malignant potential. Diagnostic imaging characteristics may sometimes suggest the diagnosis of renal oncocytoma, but cannot eliminate the main differential diagnosis, i.e. granular renal cell adenocarcinoma. When the tumor is small and unifocal, nephron sparing surgery may be considered. Whether or not the diagnosis has been confirmed by fine needle aspiration, conservative surgery must be controlled by intraoperative frozen sections of the tumor and surgical margins.
Collapse
Affiliation(s)
- G R Li
- Service d'Urologie-Andrologie, Hôpital Nord, Saint-Etienne
| | | | | | | | | | | | | |
Collapse
|
50
|
Abstract
OBJECTIVE To examine adrenal invasion by renal cell carcinoma (RCC), particularly by adrenal micrometastasis, to determine whether adrenalectomy should be performed during radical nephrectomy. PATIENTS AND METHODS From 1987 to 1994, 129 patients with RCC (90 men and 39 women, mean age 61.4 years, range 22-81) underwent radical nephrectomy with associated adrenalectomy because they had risk factors for adrenal invasion (tumour size > 5 cm. or tumour of the superior pole). Pathological examinations were carried out systematically and records of these examinations reviewed. The tumour size was recorded and the frequency of invasion calculated. RESULTS There were 10 cases where the gland was invaded: one was a synchronous contralateral metastasis and nine (7%) were ipsilateral invasions of which two were tumours in the superior pole that invaded the gland by direct extension and the other seven invaded the gland by distant metastasis, six being micrometastatic (4.7%). A single micrometastasis was found in two cases (1.5%). There was no adrenal invasion by tumours of < 5 cm in diameter from the superior pole. When only tumours > 5 cm in diameter were considered, the ipsilateral invasion rate was 11% (9/80) and the micrometastatic rate was 7.5% (6/80). CONCLUSION Adrenalectomy need not be performed routinely in small tumours which are detected early, but the possibility of adrenal micrometastasis from larger tumours (> 5 cm) should be considered.
Collapse
Affiliation(s)
- G R Li
- Department of Urology and Pathology, Hospital of Rangueil, CHU Toulouse, France
| | | | | | | | | |
Collapse
|